指南与共识乳腺乳腺X线MR

ESR要点:乳腺癌治疗后监测——从乳腺X线摄影到更个性化方法——欧洲乳腺影像学会实践推荐

ESR Essentials: post-treatment breast cancer surveillance from mammography to a more personalised approach-practice recommendations by the European Society of Breast Imaging.
指南 / 共识 · Eur Radiol · 2025-08-14

文章讨论乳腺X线摄影在乳腺癌治疗后随访中的作用及附加影像技术的使用,指出乳腺X线摄影是随访的标准影像技术但敏感度受乳腺密度和治疗后改变影响,强调基于个体风险因素的个性化随访和共同决策,并给出五年年度双体位乳腺X线摄影为监测随访标准检查等要点。

要点

  • 五年年度双体位乳腺X线摄影是监测随访的标准检查。
  • 充分认识乳腺术后正常改变对避免不必要检查至关重要。
  • 监测随访应从「一刀切」转向更个性化方法。

核心结论

  • 乳腺X线摄影是乳腺癌治疗后随访的标准影像技术,但其敏感度受乳腺密度和治疗后改变影响。
  • 对于基因突变携带者或乳腺癌风险高于20%的患者,需要高风险筛查方案。
  • 非基因突变携带者可能需要补充影像检查。
  • 致密乳腺且诊断时年轻的患者应接受对比增强影像检查。
  • MRI仍是最敏感的检查工具但存在局限性,对比增强乳腺X线摄影(CEM)是更可负担的替代选择。

研究设计与样本

  • 欧洲乳腺影像学会(European Society of Breast Imaging)发布的实践推荐。

诊断标准与关键数值

  • 基因突变携带者或乳腺癌风险高于20%的患者需要高风险筛查方案。
  • 五年年度双体位乳腺X线摄影是监测随访的标准检查。
  • 现行标准要求术后乳腺X线摄影年度监测至少5年。
  • 致密乳腺且诊断时年轻的患者应接受对比增强影像检查。

临床应用与阅片要点

  • 充分认识乳腺术后正常改变对避免不必要检查至关重要。
  • 监测随访应从「一刀切」转向更个性化方法。
  • 通过评估个体风险因素和让患者参与共同决策来实施这些推荐。

局限性

  • MRI仍是最敏感的检查工具但存在局限性。
  • 需要优化监测方案并确保所有乳腺癌幸存者公平获得适当的影像检查方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The breast cancer long-term survival rate has improved; early detection of local recurrence and second primary cancers has been crucial to this success. Mammography is the standard imaging technique for follow-up, but its sensitivity is affected by breast density and post-treatment changes. This article discusses the role of mammography in the follow-up of women after breast cancer treatment, and the use of additional imaging techniques. For patients with genetic mutations or a risk of breast cancer above 20%, high-risk screening protocols are necessary. Non-genetic mutation carriers may require supplemental imaging. Contrast imaging should be offered to women with dense breasts and a young age at diagnosis. While MRI remains the most sensitive tool, it has limitations, and contrast-enhanced mammography (CEM) emerges as a more affordable alternative. Current standards dictate the use of post-operative mammography annual surveillance for at least 5 years. As surveillance strategies evolve, the importance of personalised follow-up based on individual risk factors is emphasised. In fact, there is a need to optimise surveillance protocols and ensure equitable access to appropriate imaging methods for all breast cancer survivors. These recommendations can be implemented into practice by evaluating individual risk factors and engaging patients in shared decision-making. KEY POINTS: Adequate knowledge of normal post-surgical changes of the breast is crucial for avoiding unnecessary work-up. Five-year annual two-view mammography is the standard test for surveillance follow-up. Surveillance follow-up should move beyond a "one size fits all" to a more personalised approach.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Giannotti E, Pasculli M, Sella T, et al. ESR Essentials: post-treatment breast cancer surveillance from mammography to a more personalised approach-practice recommendations by the European Society of Breast Imaging. Eur Radiol. 2025. PMID: 40813505. doi:10.1007/s00330-025-11819-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。